Effect of change in vascular access on patient mortality in hemodialysis patients

被引:162
作者
Allon, M
Daugirdas, J
Depner, TA
Greene, T
Ornt, D
Schwab, SJ
机构
[1] Univ Alabama, Div Nephrol, Birmingham, AL 35233 USA
[2] Univ Illinois, Chicago, IL USA
[3] Univ Calif Davis, Davis, CA 95616 USA
[4] Cleveland Clin, Cleveland, OH 44106 USA
[5] Case Western Reserve Univ, Cleveland, OH 44106 USA
[6] Med Coll Georgia, Augusta, GA 30912 USA
关键词
vascular access; fistula; graft; catheter; mortality;
D O I
10.1053/j.ajkd.2005.11.023
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Hemodialysis patients using a catheter have a greater mortality risk than those using an arteriovenous (AV) access (fistula or graft). However, catheter-dependent patients also differ from those with an AV access in several clinical features, and these differences may themselves contribute to their excess mortality. Methods: The current study evaluates whether a change in vascular access affects risk for mortality in patients enrolled in the Hemodialysis Study. Time-dependent Cox regression was used to relate mortality risk to current type of access and change In access type during the preceding 1 year. Results: Compared with patients who dialyzed using an AV access at both the beginning and end of the preceding 1-year interval, relative risks for mortality were 3.43 (95% confidence interval [CI], 2.42 to 4.86) in patients who dialyzed with a catheter at both times; 2.38 (95% CI, 1.76 to 3.23) in patients switching from an AV access to a catheter, and 1.37 (95% CI, 0.81 to 2.32) in patients switching from a catheter to an AV access. Change from AV access to a catheter was associated with an antecedent decrease in serum albumin level (odds ratio, 1.25; 95% CI, 1.09 to 1.45 per 0.5 g/dL; P=0.002), weight loss (odds ratio, 1.14; 95% CI, 1.06 to 1.22 per 2 kg; P<0.001), and decreases in equilibrated normalized protein catabolic rate (odds ratio, 2.22; 95% CI, 1.41 to 3.57 per 0.25 g/kg/d; P<0.001) and non-access-related hospitalization (odds ratio, 1.19; 95% CI, 1.06 to 1.32 per 1 additional hospitalization over 4 months; P=0.002). Change from a catheter to AV access was predicted by only the antecedent non-access-related hospitalization rate (odds ratio, 0.93; 95% CI, 0.87 to 0.97 per 1 additional hospitalization over 4 months; P<0.001). Conclusion: Change from a catheter to AV access is associated with a substantial decrease in mortality risk.
引用
收藏
页码:469 / 477
页数:9
相关论文
共 28 条
  • [1] Allon M, 2004, AM J KIDNEY DIS, V44, P779, DOI 10.1016/S0272-6386(04)01078-9
  • [2] Impact of dialysis dose and membrane on infection-related hospitalization and death: Results of the HEMO study
    Allon, M
    Depner, TA
    Radeva, M
    Bailey, J
    Beddhu, S
    Butterly, D
    Coyne, DW
    Gassman, JJ
    Kaufman, AM
    Kaysen, GA
    Lewis, JA
    Schwab, SJ
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (07): : 1863 - 1870
  • [3] Increasing arteriovenous fistulas in hemodialysis patients: Problems and solutions
    Allon, M
    Robbin, ML
    [J]. KIDNEY INTERNATIONAL, 2002, 62 (04) : 1109 - 1124
  • [4] End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link?
    Arici, M
    Walls, J
    [J]. KIDNEY INTERNATIONAL, 2001, 59 (02) : 407 - 414
  • [5] Conversion of tunneled hemodialysis catheter-consigned patients to arteriovenous fistula
    Asif, A
    Cherla, G
    Merrill, D
    Cipleu, CD
    Briones, P
    Pennell, P
    [J]. KIDNEY INTERNATIONAL, 2005, 67 (06) : 2399 - 2406
  • [6] Comorbidity assessment in hemodialysis and peritoneal dialysis using the index of coexistent disease
    Athienites, NV
    Miskulin, DC
    Fernandez, G
    Bunnapradist, S
    Simon, G
    Landa, M
    Schmid, CH
    Greenfield, S
    Levey, AS
    Meyer, KB
    [J]. SEMINARS IN DIALYSIS, 2000, 13 (05) : 320 - 326
  • [7] Aggressive treatment of early fistula failure
    Beathard, GA
    Arnold, P
    Jackson, J
    Litchfield, T
    [J]. KIDNEY INTERNATIONAL, 2003, 64 (04) : 1487 - 1494
  • [8] Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study
    Block, GA
    Hulbert-Shearon, TE
    Levin, NW
    Port, FK
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (04) : 607 - 617
  • [9] *CTR MED MED SERV, 2004, AM J KIDNEY DIS S, V44, pS1
  • [10] Dialysis dose and the effect of gender and body size on outcome in the HEMO Study
    Depner, T
    Daugirdas, J
    Greene, T
    Allon, M
    Beck, G
    Chumlea, C
    Delmez, J
    Gotch, F
    Kusek, J
    Levin, N
    Macon, E
    Milford, E
    Owen, W
    Star, R
    Toto, R
    Eknoyan, G
    [J]. KIDNEY INTERNATIONAL, 2004, 65 (04) : 1386 - 1394